Statistics
Publications
23
Citations
7.5K
H-Index
20
Active since
2016
Kevin Bi is an author at Dana-Farber Cancer Institute specializing in oncology, immunology, and medicine.
Publications per year
2016–2025
23
23
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso, Hans W. Pope, Margaret D. Zimmer et al. · Nature · 2017 · 1.1K citations
Normalizing the environment recapitulates adult human immune traits in laboratory mice
Lalit K. Beura, Sara E. Hamilton, Kevin Bi et al. · Nature · 2016 · 1.1K citations · Full text
Life Sciences, Genetics, Immunology +14
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Jeffrey J. Ishizuka, Robert T. Manguso, Collins Cheruiyot et al. · Nature · 2018 · 715 citations · Full text
Medicine, Cancer Biology, Oncology +14
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Kevin Bi, Meng Xiao He, Ziad Bakouny et al. · Cancer Cell · 2021 · 628 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 23